Last checked at 17 Apr 2012 14:00
Oxford BioMedica plc ("Oxford BioMedica" or the "Company")
Annual Information Update for the Twelve Months to 1 April 2012
Oxford BioMedica is providing an annual information update pursuant to Prospectus Rule 5.2 made by the Financial Services Authority.
1. Announcements made via a Regulatory Information Service
Date | Announcement |
04 April 2011 | Annual Information Update |
15 April 2011 | Directors' Interest in Shares and Share Options |
03 May 2011 | Announcement of data in ProSavin® study |
04 May 2011 | Pfizer license extension |
05 May 2011 | Annual General Meeting and Board changes |
18 May 2011 | Interim management statement |
23 May 2011 | New clinical data from ProSavin® Phase I/II study |
24 May 2011 | Management and Board changes |
26 May 2011 | Block listing six monthly return |
07 June 2011 | Research agreement with ImaginAb |
28 June 2011 | Notice of results |
08 July 2011 | Holding(s) in Company |
04 August 2011 | Interim data from ProSavin® Phase I/II study |
31 August 2011 | TR-1: Notification of Major Interest in Shares |
31 August 2011 | Interim Results |
04 October 2011 | TR1 Form |
04 October 2011 | TR1 Form |
18 October 2011 | US IND approval for novel ocular product in Usher syndrome type 1B |
16 November 2011 | Interim management statement |
28 November 2011 | Block listing six monthly return |
15 December 2011 | Interim update on ProSavin® Phase I/II study |
16 December 2011 | Directors' interest in shares |
30 January 2012 | Notification of Major Interest in Shares |
10 February 2012 | Management and Board change |
24 February 2012 | Notice of results |
06 March 2012 | Preliminary results |
08 March 2012 | Director / PDMR dealings |
12 March 2012 | Significant shareholding |
22 March 2012 | TR-1 Notification of Major Interest in Shares |
Details of all regulatory announcements for Oxford BioMedica can be found on the London Stock Exchange website at www.londonstockexchange.com and on the Oxford BioMedica website at http://www.oxfordbiomedica.co.uk
2. Documents filed with Companies House
Date | Document type | Description |
9 May 2011 | RES | Resolution to authorise and allot shares and debentures, to extend share option scheme and to disapply pre-emption rights |
11 May 2011 | AA | Annual Accounts |
29 July 2011 | TM01 | Termination of appointment, director - Alan Kingsman |
29 July 2011 | TM01 | Termination of appointment, director - Alexander Lewis |
27 September 2011 | AR01 | Annual Return |
14 February 2012 | TM02 | Termination of appointment, secretary - Andrew Wood |
Copies of documents filed at Companies House can be obtained from Companies House, Crown Way, Cardiff CF14 3UZ or through Companies House Direct at www.direct.companieshouse.gov.uk
3. Documents published or sent to shareholders or filed with the UKLA National Storage Mechanism
Date | Description |
31 August 2011 | Interim Report for 6 months to 30 June 2011 |
Copies of all the above documents may be obtained from the Company Secretary at the Company's Registered Office:
This annual information update is filed pursuant to Prospectus Rule 5.2 made by the Financial Services Authority and not for any other purpose and by filing this annual information update neither the Company, nor any other person, takes any responsibility for, or makes any representation, express or implied, as to the accuracy or completeness of, the information contained or referred to below herein. The information referred to below is not necessarily up to date as at the date of this annual information update and the Company does not undertake any obligation to update any such information in the future. Furthermore, such information may have been prepared in accordance with the laws or regulations of a particular jurisdiction and may not comply with or meet the relevant standards of disclosure in any other jurisdiction. Neither this annual information update, nor the information referred to below constitutes, by virtue of this communication, an offer of any securities addressed to any person and should not be relied on by any person.
Oxford BioMedica plc
Medawar Centre
Robert Robinson Avenue
The Oxford Science Park
Oxford
OX4 4GA
17 April 2012